Tapping Into Japan’s Opportunity in Regenerative Medicine

Cell & gene therapies as well as regenerative medicines (CGT&RMs) have become invaluable tools in the fight against disease. They offer exciting biopharmaceutical opportunities to address the world’s most challenging unmet medical needs.

Interest in CGT&RMs has grown alongside the pharmaceutical and biotechnology industries in recent years;  Japan’s established, rapidly expanding market makes it the perfect location to facilitate successful CGT&RM programs. 

Discover the benefits of choosing Japan for your CGT&RM product development, manufacture and commercialization. 

Download this eBook to learn more about:

• Japan’s well-established CGT&RM market 
• An aging population in growing need of novel therapies
• An enabling regulatory environment and governmental investment in CGT&RM success